These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

922 related items for PubMed ID: 28795324

  • 1. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y, Olauson H, Vavilis G, Hammar U, Herthelius M, Axelsson J, Bárány P.
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [Abstract] [Full Text] [Related]

  • 2. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M, Smith C, Shah V, Gullet A, Wells D, Rees L, Shroff R.
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [Abstract] [Full Text] [Related]

  • 3. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [Abstract] [Full Text] [Related]

  • 4. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
    Gan L, Zhou Q.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep 28; 42(9):1058-1065. PubMed ID: 28989152
    [Abstract] [Full Text] [Related]

  • 5. Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Edmonston D, Fuchs MAA, Burke EJ, Isakova T, Wolf M, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.
    Am J Kidney Dis; 2024 Sep 28; 84(3):349-360.e1. PubMed ID: 38583756
    [Abstract] [Full Text] [Related]

  • 6. Association between circulating FGF23, α-Klotho, and left ventricular diastolic dysfunction among patients with preserved ejection fraction.
    Okamoto Y, Fujita S, Morita H, Kizawa S, Ito T, Sakane K, Sohmiya K, Hoshiga M, Ishizaka N.
    Heart Vessels; 2016 Jan 28; 31(1):66-73. PubMed ID: 25223536
    [Abstract] [Full Text] [Related]

  • 7. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY, Milovanov YS, Kudryavtseva DV, Markina MM, Milovanova SY, Kozlovskaya LV, Lebedeva MV, Beketov VD, Moiseev SV, Mukhin NA, Fomin VV, Svistunov AA.
    Ter Arkh; 2015 Jan 28; 87(6):10-16. PubMed ID: 26281189
    [Abstract] [Full Text] [Related]

  • 8. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S, Fujita S, Kizawa S, Morita H, Ishizaka N.
    PLoS One; 2016 Jan 28; 11(7):e0156860. PubMed ID: 27400031
    [Abstract] [Full Text] [Related]

  • 9. [Mineral metabolism in patients on chronic peritoneal dialysis].
    Ceballos O ML, Rojo L A, Azócar P M, Ibacache M MJ, Delucchi B A, Quiroz Z L, Irarrázabal M C, Delgado B I, Ugarte P F, Cano Sch F.
    Rev Chil Pediatr; 2014 Feb 28; 85(1):31-9. PubMed ID: 25079181
    [Abstract] [Full Text] [Related]

  • 10. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
    Krishnasamy R, Tan SJ, Hawley CM, Johnson DW, Stanton T, Lee K, Mudge DW, Campbell S, Elder GJ, Toussaint ND, Isbel NM.
    BMC Nephrol; 2017 Sep 04; 18(1):281. PubMed ID: 28870151
    [Abstract] [Full Text] [Related]

  • 11. Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients.
    Ozeki M, Fujita S, Kizawa S, Morita H, Sohmiya K, Hoshiga M, Ishizaka N.
    BMC Nephrol; 2014 Sep 08; 15():147. PubMed ID: 25200959
    [Abstract] [Full Text] [Related]

  • 12. Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients.
    Silva AP, Mendes F, Carias E, Gonçalves RB, Fragoso A, Dias C, Tavares N, Café HM, Santos N, Rato F, Leão Neves P, Almeida E.
    Int J Mol Sci; 2019 Mar 27; 20(7):. PubMed ID: 30934737
    [Abstract] [Full Text] [Related]

  • 13. The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study.
    Kim HJ, Kang E, Oh YK, Kim YH, Han SH, Yoo TH, Chae DW, Lee J, Ahn C, Oh KH.
    BMC Nephrol; 2018 Mar 05; 19(1):51. PubMed ID: 29506503
    [Abstract] [Full Text] [Related]

  • 14. Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.
    Sinha MD, Turner C, Booth CJ, Waller S, Rasmussen P, Goldsmith DJ, Simpson JM.
    Pediatr Nephrol; 2015 Oct 05; 30(10):1843-52. PubMed ID: 25975437
    [Abstract] [Full Text] [Related]

  • 15. [Potential application of fibroblast growth factor 23-klotho axis in chronic kidney disease].
    Lacroix JS, Urena-Torres P.
    Nephrol Ther; 2020 Mar 05; 16(2):83-92. PubMed ID: 31843356
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
    Shimamura Y, Hamada K, Inoue K, Ogata K, Ishihara M, Kagawa T, Inoue M, Fujimoto S, Ikebe M, Yuasa K, Yamanaka S, Sugiura T, Terada Y.
    Clin Exp Nephrol; 2012 Oct 05; 16(5):722-9. PubMed ID: 22457086
    [Abstract] [Full Text] [Related]

  • 17. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM, Betoko A, Schneider MF, Salusky IB, Wolf MS, Jüppner H, Warady BA, Furth SL, Portale AA.
    Clin J Am Soc Nephrol; 2018 Jan 06; 13(1):45-52. PubMed ID: 29025789
    [Abstract] [Full Text] [Related]

  • 18. Assessing longitudinal trends in cardiac function among pediatric patients with chronic kidney disease.
    Tranæus Lindblad Y, Vavilis G, Axelsson J, Herthelius M, Bárány P.
    Pediatr Nephrol; 2016 Sep 06; 31(9):1485-97. PubMed ID: 27056063
    [Abstract] [Full Text] [Related]

  • 19. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
    Hu S, Wang D, Zhang R, Cao Y, Jin H, Mao Y, Wei L, Ren K, Zhang X, Wang Y.
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec 30; 38(12):1427-1432. PubMed ID: 30613009
    [Abstract] [Full Text] [Related]

  • 20. FGF23 and Klotho in chronic kidney disease.
    Olauson H, Larsson TE.
    Curr Opin Nephrol Hypertens; 2013 Jul 30; 22(4):397-404. PubMed ID: 23666415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.